OÜ PharmandiaRegistered
Key figures
3 090 545 €+2,0%
Revenue 2025
+4,4%
Average annual growth 2019–2025
Ratios
20252,9%
Profit margin
3,5%
EBITDA margin
−197,2%
Equity ratio
0,3×
Current ratio
−8,0%
Return on equity
828 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 807 446 € | 12 | 13 044 € |
| Q1 2026 | 847 938 € | 9 | 12 778 € |
| Q4 2025 | 851 244 € | 9 | 13 412 € |
| Q3 2025 | 692 435 € | 10 | 14 433 € |
| Q2 2025 | 740 671 € | 12 | 13 402 € |
| Q1 2025 | 773 850 € | 12 | 15 780 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2025
No dividends were distributed.
History
20250 €
20240 €
2023 ~511 789 €
20220 €
20210 €
20200 €
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 550 868 | 726 816 | 720 920 | 784 347 | 584 476 | 567 057 | 561 147 |
| Total non-current assets | 662 291 | 745 194 | 652 163 | 559 697 | 10 925 | 8861 | 6798 |
| Total assets | 1 213 159 | 1 472 010 | 1 373 083 | 1 344 044 | 595 401 | 575 918 | 567 945 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 1 746 512 | 2 095 101 | 1 984 991 | 2 055 954 | 1 889 101 | 1 785 377 | 1 688 110 |
| Non-current liabilities | — | — | — | — | — | — | — |
| Total liabilities | 1 746 512 | 2 095 101 | 1 984 991 | 2 055 954 | 1 889 101 | 1 785 377 | 1 688 110 |
| Share capital | 3000 | 3000 | 3000 | 3000 | 3000 | 3000 | 3000 |
| Retained earnings of previous periods | −221 155 | −492 168 | −626 092 | −614 908 | −1 229 199 | −1 299 200 | −1 214 959 |
| Profit for the year | −315 198 | −133 923 | 11 184 | −100 002 | −70 001 | 84 241 | 89 294 |
| Reserves and other equity | — | — | — | — | 2500 | 2500 | 2500 |
| Total equity | −533 353 | −623 091 | −611 908 | −711 910 | −1 293 700 | −1 209 459 | −1 120 165 |
| Income statement | |||||||
| Sales revenue | 2 386 847 | 2 574 755 | 2 589 684 | 2 778 271 | 3 052 501 | 3 030 463 | 3 090 545 |
| Operating profit | −272 859 | −84 150 | 60 824 | −47 718 | 12 364 | 104 612 | 106 629 |
| EBITDA | −193 748 | 5007 | 153 569 | 44 748 | 79 433 | 106 675 | 108 692 |
| Profit before income tax | −315 198 | −133 923 | 11 184 | −100 002 | −70 001 | 84 241 | 89 294 |
| Profit for the reporting year | −315 198 | −133 923 | 11 184 | −100 002 | −70 001 | 84 241 | 89 294 |
| Labour costs | 460 110 | 352 136 | 57 847 | 106 155 | 126 918 | 151 305 | 126 469 |
| Depreciation of non-current assets | 79 111 | 89 157 | 92 745 | 92 466 | 67 069 | 2063 | 2063 |
| Other indicators | |||||||
| Employees | 20 | 18 | 2 | 3 | 4 | 4 | 4 |
| Calculated dividend | — | 0 | 0 | 0 | 511 789 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
CompanyPersonShareholderOther roleAdditional link
Related companies
Same activity — Ravimite jaemüük